UPDATE
: Monday, September 7, 2020
Home
Login
Mobile Version
All
Hospital
Pharma
Bio
Korea‘s Bio Industry
Device/ICT
Policy
People
Life science
Special
Innovation for Survival
Korea’s medical culture series
Korea’s New Candidate Drug Watch List
Special Series in Celebration of KBR's 1st Anniversary
Interview with foreign envoys
Special Series in Celebration of KBR’s 2nd Anniversary
Interview with global pharma
Special Series in Celebration of KBR’s 3rd Anniversary
Special Series in Celebration of KBR’s 4th Anniversary
ASCO 2020 Highlights
Opinion
Reporter’s Notebook
Search
트위터
페이스북
RSS
상단여백
제목보기
제목보기
제목+내용
Physicians call for tighter control of botulinum toxin strains
The medical community has come forth to urge the health authorities to moni...
by So Jae-hyeon
|
2018-04-12 16:33
라인
Daewoong opens biotech research lab in Indonesia
Daewoong Pharmaceutical said it has established a biotech research center a...
by So Jae-hyeon
|
2018-04-12 11:37
라인
Software expert to head Veeva Systems Korea
Veeva Systems Korea, a cloud-based software provider for pharmaceutical and...
by So Jae-hyeon
|
2018-04-10 16:14
라인
LG Chem, Merck to co-market hypertension drug
LG Chem and Merck Biopharma Korea said Monday the two firms agreed to sell ...
by So Jae-hyeon
|
2018-04-10 15:15
라인
Biotech CEOs roll up sleeves for global biz
CEOs of Korea’s major biotech companies are directly involving in marketing...
by So Jae-hyeon
|
2018-04-10 12:09
라인
Tamiflu crushed generic copies in flu season
Despite the massive release of generic copies with the expiration of Tamifl...
by So Jae-hyeon
|
2018-04-09 15:40
라인
Biosimilars take on original at breast cancer conference
Industry officials said they were able to witness the advent of biosimilar ...
by So Jae-hyeon
|
2018-04-09 15:05
라인
Janssen, Hanmi start phase-2 study on obesity, diabetes drug
Janssen and Hanmi Pharmaceutical will start a global phase-2 clinical trial...
by So Jae-hyeon
|
2018-04-05 15:06
라인
Korean biosimilars rarely prescribed in US
Korean biosimilar products are still struggling to penetrate the U.S. marke...
by So Jae-hyeon
|
2018-04-05 15:05
라인
Will SGLT-2 combos with DPP-4 win insurance coverage?
Suppliers of antidiabetic medicines are paying attention to whether SGLT-2 ...
by So Jae-hyeon
|
2018-04-04 15:12
라인
Outpatient drug prescriptions plunged in February
The outpatient drug prescriptions market saw a drastic contraction in Febru...
by So Jae-hyeon
|
2018-04-03 16:59
라인
Steelmaker POSCO to challenge biotech sector
Korea’s largest steelmaker POSCO is entering the pharmaceutical market.Kwon...
by So Jae-hyeon
|
2018-04-03 11:58
라인
Chinese lab ends Olita deal with Hanmi
China’s biotech firm Zai Lab has returned the exclusive sales license of an...
by So Jae-hyeon
|
2018-04-02 11:39
라인
Daewoong, Yuhan in new rivalry to sell antidiabetic drugs
Daewoong Pharmaceutical and Yuhan Corp, both boasting strong marketing powe...
by So Jae-hyeon
|
2018-03-30 16:23
라인
Dongkoo Bio inks deal to sell OTC prostate drug
Dongkoo Bio & Pharma said it has signed a licensing-in deal with Swedish dr...
by So Jae-hyeon
|
2018-03-29 14:18
라인
Drugmakers step up anti-fine dust marketing
Pharmaceutical companies are focusing their marketing activities on fightin...
by So Jae-hyeon
|
2018-03-28 11:35
라인
Drugmakers seek partners to boost diabetes business
Pharmaceutical companies are seeking new partners to boost drug sales in th...
by So Jae-hyeon
|
2018-03-26 12:33
라인
Pharmicell aims to test dendritic cell-based cancer drug this year
A local stem cell developer has raised a possibility that dendritic cells m...
by So Jae-hyeon
|
2018-03-23 16:41
라인
Myongji Hospital, Cancer Rop team up to fight cancer
Myongji Hospital and Cancer Rop, a biotech firm formerly known as MGMed, ce...
by So Jae-hyeon
|
2018-03-23 15:48
라인
Anticoagulant latecomer Lixiana outrivals Eliquis
The competition between No.2 and No.3 next-generation anticoagulant is heat...
by So Jae-hyeon
|
2018-03-22 16:12
-
1
2
3
4
5
6
7
8
9
10
-
176 civic groups furious over government-doctors deal
Amgen Korea wins new indication for acute lymphoblastic leukemia drug
UBcare wins patent for tech to monitor suspected infectious diseases
SCM Lifescience punished for delaying adverse reaction report
176 civic groups furious over government-doctors deal
Amgen Korea wins new indication for acute lymphoblastic leukemia drug
UBcare wins patent for tech to monitor suspected infectious diseases
SCM Lifescience punished for delaying adverse reaction report
여백
Most viewed
1
‘Cyramza helped improve gastric cancer treatment in Korea’
2
‘Reduced-dose prasugrel effective for ACS patients undergoing PCI’
3
Amgen Korea wins new indication for acute lymphoblastic leukemia drug
4
SNUBH develops AI model predicting patients at risk of cerebral aneurysm
5
Novavax releases encouraging phase-1 results on Covid-19 vaccine candidate
6
LG Chem, SK Bioscience end sales partnership with Daewoong
7
UBcare wins patent for tech to monitor suspected infectious diseases
8
176 civic groups furious over government-doctors deal
9
Recovered Covid-19 patients suffer from aftereffects – for long
10
Regulator OKs JW Pharma's rheumarthritis drug for treating giant cell arteries
여백
Opinion
[Column] Correct diagnosis leads to proper treatment
[Column] How ongoing doctors’ strike is different from 20 years ago
A Korean-American Doctor asks: Is Korea truly in 2020?
여백
Back to Top